Northern Trust
ASMB icon

Northern Trust’s Assembly Biosciences ASMB Stock Holding History

Northern Trust’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.14M Sell
41,014
-213
-0.5% -$6.08K ﹤0.01% 3274
2025
Q4 		$1.4M Buy
41,227
+1,272
+3% +$41K ﹤0.01% 3193
2025
Q3 		$1.02M Buy
39,955
+11,880
+42% +$261K ﹤0.01% 3397
2025
Q2 		$509K Sell
28,075
-248
-0.9% -$3.27K ﹤0.01% 3642
2025
Q1 		$271K Sell
28,323
-326
-1% -$4.26K ﹤0.01% 3829
2024
Q4 		$452K Sell
28,649
-1,175
-4% -$18.9K ﹤0.01% 3696
2024
Q3 		$452K Buy
29,824
+18,257
+158% +$278K ﹤0.01% 3606
2024
Q2 		$159K Buy
11,567
+1,008
+10% +$14.4K ﹤0.01% 3931
2024
Q1 		$140K Sell
10,559
-373
-3% -$4.35K ﹤0.01% 3991
2023
Q4 		$108K Buy
10,932
+1,922
+21% +$18.3K ﹤0.01% 4100
2023
Q3 		$95.7K Hold
9,010
– – ﹤0.01% 4024
2023
Q2 		$124K Buy
9,010
+810
+10% +$9.95K ﹤0.01% 3979
2023
Q1 		$82.7K Buy
8,200
+577
+8% +$9.73K ﹤0.01% 4126
2022
Q4 		$119K Sell
7,623
-27
-0.4% -$462 ﹤0.01% 4038
2022
Q3 		$151K Buy
7,650
+222
+3% +$5.37K ﹤0.01% 3984
2022
Q2 		$187K Sell
7,428
-297
-4% -$6.83K ﹤0.01% 3960
2022
Q1 		$191K Sell
7,725
-823
-10% -$17.7K ﹤0.01% 4145
2021
Q4 		$239K Sell
8,548
-342
-4% -$11.2K ﹤0.01% 4130
2021
Q3 		$371K Buy
8,890
+376
+4% +$15.8K ﹤0.01% 3880
2021
Q2 		$396K Sell
8,514
-22,413
-72% -$1.11M ﹤0.01% 3815
2021
Q1 		$1.71M Sell
30,927
-1,869
-6% -$124K ﹤0.01% 3325
2020
Q4 		$2.38M Sell
32,796
-1,355
-4% -$159K ﹤0.01% 3111
2020
Q3 		$6.74M Sell
34,151
-1,052
-3% -$265K ﹤0.01% 2349
2020
Q2 		$9.85M Buy
35,203
+4,211
+14% +$982K ﹤0.01% 2105
2020
Q1 		$5.52M Buy
30,992
+6,297
+25% +$1.35M ﹤0.01% 2244
2019
Q4 		$6.06M Sell
24,695
-172
-0.7% -$31.7K ﹤0.01% 2474
2019
Q3 		$2.93M Buy
24,867
+1,411
+6% +$213K ﹤0.01% 2867
2019
Q2 		$3.8M Sell
23,456
-790
-3% -$150K ﹤0.01% 2703
2019
Q1 		$5.73M Buy
24,246
+458
+2% +$116K ﹤0.01% 2482
2018
Q4 		$6.46M Sell
23,788
-565
-2% -$163K ﹤0.01% 2345
2018
Q3 		$10.9M Buy
24,353
+4,256
+21% +$1.99M ﹤0.01% 2214
2018
Q2 		$9.46M Buy
20,097
+1,514
+8% +$801K ﹤0.01% 2302
2018
Q1 		$11M Buy
18,583
+242
+1% +$150K ﹤0.01% 2110
2017
Q4 		$9.96M Buy
18,341
+2,428
+15% +$1.1M ﹤0.01% 2190
2017
Q3 		$6.67M Sell
15,913
-364
-2% -$112K ﹤0.01% 2449
2017
Q2 		$4.03M Buy
16,277
+11,210
+221% +$3.16M ﹤0.01% 2748
2017
Q1 		$1.55M Buy
5,067
+888
+21% +$218K ﹤0.01% 3199
2016
Q4 		$609K Buy
4,179
+808
+24% +$120K ﹤0.01% 3480
2016
Q3 		$292K Buy
3,371
+75
+2% +$5.79K ﹤0.01% 3634
2016
Q2 		$220K Sell
3,296
-11,310
-77% -$742K ﹤0.01% 3695
2016
Q1 		$880K Buy
14,606
+46
+0.3% +$3.08K ﹤0.01% 3296
2015
Q4 		$1.31M Buy
14,560
+619
+4% +$67.4K ﹤0.01% 3227
2015
Q3 		$1.6M Buy
13,941
+11,087
+388% +$1.95M ﹤0.01% 3158
2015
Q2 		$660K Buy
+2,854
New +$551K ﹤0.01% 3486
2014
Q3 		– Sell
-550
Closed -$43K – 4307
2014
Q2 		$43K Hold
550
– – ﹤0.01% 4124
2014
Q1 		$42K Hold
550
– – ﹤0.01% 4066
2013
Q4 		$126K Buy
550
+126
+30% +$22.9K ﹤0.01% 3825
2013
Q3 		$74K Sell
424
-1,783
-81% -$273K ﹤0.01% 3870
2013
Q2 		$318K Buy
+2,207
New +$346K ﹤0.01% 3552

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Northern Trust's ASMB Position: Q1 2026 in Review

Northern Trust reduced its Assembly Biosciences (ASMB) stake by 0.52% in Q1 2026, selling an estimated $6.08K and leaving 41,014 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #3274.

Northern Trust first reported a position in ASMB in Q2 2013 and has held it in 49 quarters since. The position peaked at $11M in Q1 2018. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

  • Northern Trust held 41,014 shares of Assembly Biosciences worth $1.14M as of Q1 2026.
  • Northern Trust sold 213 Assembly Biosciences shares in Q1 2026, an estimated $6.08K.
  • Assembly Biosciences made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3274 holding.
  • Northern Trust first reported a position in Assembly Biosciences in Q2 2013 and has held it in 49 quarters since.
  • Northern Trust's Assembly Biosciences position peaked at $11M in Q1 2018.
  • 75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.